Oct 20, 2022 4:05 pm EDT Codexis to Report Third Quarter 2022 Financial Results on November 3 Read More
Oct 3, 2022 8:00 am EDT Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer Read More
Oct 3, 2022 8:00 am EDT Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors Read More
Sep 14, 2022 4:05 pm EDT Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field Read More
Aug 2, 2022 4:05 pm EDT Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis Read More
Jul 14, 2022 4:06 pm EDT Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) Read More
Jul 14, 2022 4:05 pm EDT Codexis Announces Preliminary Second Quarter 2022 Results and Updates Guidance Read More
Jun 17, 2022 8:00 am EDT Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native Peptides Read More